Pancreatic Cancer Research

ResearcherActive in the last 2 years

Massimiliano Dall’Ora

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7790-9859; OpenAlex author ID A5044129453. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper

Papers 2

  1. Combining gemcitabine and MSC delivering soluble TRAIL to target pancreatic adenocarcinoma and its stroma. First author DOI 10.1016/j.xcrm.2024.101685↗
  2. TRAIL receptors are expressed in both malignant and stromal cells in pancreatic ductal adenocarcinoma. Co-author PMID 34659901↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Carlotta Spano · 2 shared papers, 2021–2024 · strength 0.26
  2. Andrea Spallanzani · 2 shared papers, 2021–2024 · strength 0.26
  3. Giulia Grisendi · 2 shared papers, 2021–2024 · strength 0.26
  4. Massimo Dominici · 2 shared papers, 2021–2024 · strength 0.26
  5. Giulia Rovesti · 1 shared paper, 2021 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.